BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Historical Portfolio Holders from Q1 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Debt / NOTE 2.250% 2/0
Principal, excl. options Q1 2024
609 M
Holdings value Q1 2024
$532 M
Value change Q1 2024
-$20.6 B
Grand Portfolio weight change Q1 2024
-0.043%
Number of holders
37
Number of buys Q1 2024
17
Number of sells Q1 2024
-17
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.197%
CUSIP
10806XAD4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q1 $609 M $532 M -$20.6 B $0.82 37
2023 Q4 $606 M $521 M +$29.4 M $0.85 36
2023 Q3 $578 M $465 M +$44 M $0.75 40
2023 Q2 $475 M $320 M +$7.89 M $0.62 38
2023 Q1 $465 M $323 M -$7.13 B $0.64 40
2022 Q4 $484 M $488 M -$1.15 M $0.39 33
2022 Q3 $476 M $547 M -$37.6 M $0.44 31
2022 Q2 $574 M $240 M -$26 M $0.41 33
2022 Q1 $623 M $306 M +$298 M $0.48 35